GRISEOFULVIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Griseofulvin, and what generic alternatives are available?
Griseofulvin is a drug marketed by Actavis Mid Atlantic, Chartwell Rx, Cipla, Cosette, Sandoz, Sigmapharm Labs Llc, and Mountain. and is included in nine NDAs.
The generic ingredient in GRISEOFULVIN is griseofulvin, ultramicrosize. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the griseofulvin, ultramicrosize profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Griseofulvin
A generic version of GRISEOFULVIN was approved as griseofulvin, ultramicrosize by MOUNTAIN on January 9th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GRISEOFULVIN?
- What are the global sales for GRISEOFULVIN?
- What is Average Wholesale Price for GRISEOFULVIN?
Summary for GRISEOFULVIN
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 75 |
| Clinical Trials: | 13 |
| Patent Applications: | 5,322 |
| Drug Prices: | Drug price information for GRISEOFULVIN |
| DailyMed Link: | GRISEOFULVIN at DailyMed |
Recent Clinical Trials for GRISEOFULVIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Henry Ford Health System | N/A |
| GlaxoSmithKline | Phase 1 |
| Laboratorios Grossman, S.A. | Phase 3 |
Pharmacology for GRISEOFULVIN
| Drug Class | Tubulin Inhibiting Agent |
| Physiological Effect | Decreased Mitosis Microtubule Inhibition |
US Patents and Regulatory Information for GRISEOFULVIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | GRISEOFULVIN | griseofulvin, microsize | SUSPENSION;ORAL | 065394-001 | Jul 6, 2007 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sigmapharm Labs Llc | GRISEOFULVIN | griseofulvin, microsize | TABLET;ORAL | 202482-001 | Oct 22, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Cosette | GRISEOFULVIN | griseofulvin, microsize | SUSPENSION;ORAL | 065438-001 | Oct 8, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sigmapharm Labs Llc | GRISEOFULVIN,ULTRAMICROSIZE | griseofulvin, ultramicrosize | TABLET;ORAL | 202545-001 | Oct 22, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mountain | GRISEOFULVIN, ULTRAMICROSIZE | griseofulvin, ultramicrosize | TABLET;ORAL | 204371-001 | Jan 9, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | GRISEOFULVIN | griseofulvin, microsize | SUSPENSION;ORAL | 065200-001 | Mar 2, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
